Hemophilia A Clinical Trials in Los Angeles, California
5 recruitingLos Angeles, California
Showing 1–5 of 5 trials
Recruiting
Phase 1
A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
Severe Hemophilia A
Pfizer15 enrolled4 locationsNCT06703606
Recruiting
Phase 1
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
Healthy ParticipantsHemophilia AHemophilia B+1 more
Equilibra Bioscience LLC31 enrolled10 locationsNCT06349473
Recruiting
Phase 4
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Hemophilia A With InhibitorHemophilia B With Inhibitor
American Thrombosis and Hemostasis Network55 enrolled21 locationsNCT04647227
Recruiting
Phase 4
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Hemophilia A
Sanofi20 enrolled2 locationsNCT06145373
Recruiting
Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A
Hemophilia A
Washington Institute for Coagulation40 enrolled4 locationsNCT04131036